DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 53 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,085,000 | +200.9% | 103,422 | +281.8% | 0.00% | +100.0% |
| Q1 2021 | $693,000 | -72.8% | 27,090 | -76.6% | 0.00% | -50.0% |
| Q4 2020 | $2,552,000 | +8.4% | 115,845 | -11.5% | 0.00% | 0.0% |
| Q3 2020 | $2,355,000 | -38.9% | 130,923 | -13.8% | 0.00% | -60.0% |
| Q2 2020 | $3,856,000 | +30.5% | 151,817 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $2,955,000 | +12.4% | 160,849 | +34.9% | 0.01% | +66.7% |
| Q4 2019 | $2,628,000 | +750.5% | 119,270 | +453.8% | 0.00% | – |
| Q3 2019 | $309,000 | +782.9% | 21,537 | +75.7% | 0.00% | – |
| Q4 2016 | $35,000 | -88.6% | 12,257 | -76.6% | 0.00% | -100.0% |
| Q3 2016 | $308,000 | +37.5% | 52,340 | -30.0% | 0.00% | – |
| Q2 2016 | $224,000 | +5.7% | 74,791 | +89.5% | 0.00% | – |
| Q1 2016 | $212,000 | -25.6% | 39,475 | +64.5% | 0.00% | – |
| Q4 2015 | $285,000 | -20.8% | 23,994 | +60.2% | 0.00% | -100.0% |
| Q1 2015 | $360,000 | +0.8% | 14,978 | -30.8% | 0.00% | – |
| Q4 2014 | $357,000 | -51.0% | 21,658 | -16.1% | 0.00% | -100.0% |
| Q1 2014 | $729,000 | – | 25,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |